click below
click below
Normal Size Small Size show me how
Pain, Hema, Onco 1
Pain, Hema, Onco 1 Essential Knowledge
| Generic/Brand | Side effects |
|---|---|
| Fentanyl/ Transdermal: Duragesic, IV: Sublimaze KSE | Key Side Effects: dizziness, drowsiness, itching, nausea, vomiting, constipation, respiratory depression (dose-related). |
| Fentanyl/ Transdermal: Duragesic, IV: Sublimaze US WARN | US Warn (all opioid analgesics) risk of opioid addiction, abuse, & misuse which leads to overdose & death; serious, life-threatening, or fatal respira depression may occur; accidental ingestion results fatal overdose; prolonged use in pregnancy results neonatal opioid withdrawal syndrome; abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzo or CNS depressants (alcohol), may result in profound sedation, respiratory depression, coma, and death. |
| Hydromorphone/ Dilaudid (PO, IV) KSE | Key Side Effects: dizziness, drowsiness, itching, nausea, vomiting, constipation, respiratory depression (dose-related). |
| Hydromorphone/ Dilaudid (PO, IV) US WARN | US Warn (all opioid analgesics) risk of opioid addiction, abuse, & misuse which leads to overdose & death; serious, life-threatening, or fatal respira depression may occur; accidental ingestion results fatal overdose; prolonged use in pregnancy results neonatal opioid withdrawal syndrome; abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzo or CNS depressants (alcohol), may result in profound sedation, respiratory depression, coma, and death. |
| Morphine ER/ MS Contin, Kadian (PO) KSE | Key Side Effects: dizziness, drowsiness, itching, nausea, vomiting, constipation, respiratory depression (dose-related). |
| Morphine ER/ MS Contin, Kadian (PO) US WARN | US Warn (all opioid analgesics) risk of opioid addiction, abuse, & misuse which leads to overdose & death; serious, life-threatening, or fatal respira depression may occur; accidental ingestion results fatal overdose; prolonged use in pregnancy results neonatal opioid withdrawal syndrome; abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzo or CNS depressants (alcohol), may result in profound sedation, respiratory depression, coma, and death. |
| Morphine IR/ IV: Duramorph (PO, IV, IM, PR) KSE | Key Side Effects: dizziness, drowsiness, itching, nausea, vomiting, constipation, respiratory depression (dose-related). |
| Morphine IR/ IV: Duramorph (PO, IV, IM, PR) US WARN | US Warn (all opioid analgesics) risk of opioid addiction, abuse, & misuse which leads to overdose & death; serious, life-threatening, or fatal respira depression may occur; accidental ingestion results fatal overdose; prolonged use in pregnancy results neonatal opioid withdrawal syndrome; abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzo or CNS depressants (alcohol), may result in profound sedation, respiratory depression, coma, and death. |
| Oxycodone/ Oxycontin, Roxicodone (PO) KSE | Key Side Effects: dizziness, drowsiness, itching, nausea, vomiting, constipation, respiratory depression (dose-related). |
| Oxycodone/ Oxycontin, Roxicodone (PO) US WARN | US Warn (all opioid analgesics) risk of opioid addiction, abuse, & misuse which leads to overdose & death; serious, life-threatening, or fatal respira depression may occur; accidental ingestion results fatal overdose; prolonged use in pregnancy results neonatal opioid withdrawal syndrome; abrupt discontinuation may result in serious opioid-induced withdrawal syndrome; concomitant use of opioids with benzo or CNS depressants (alcohol), may result in profound sedation, respiratory depression, coma, and death. |
| Methadone/ Dolophine (PO, IV) | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related), QTc prolongation. US Boxed Warnings (all opioid analgesics): See above. US Boxed Warnings (only for methadone): QTc interval prolongation and serious arrhythmia (Torsades de Pointes) have occurred during treatment. |
| Acetaminophen/ PO/PR: Tylenol, IV: Ofirmev (PO, PR, IV) | Key Side Effects: nausea, vomiting, increased hepatic transaminases. US Boxed Warnings: total daily dose from all sources should not exceed maximum daily limit; hepatotoxicity. |
| Tramadol/ Ultram, ER (PO) | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related). US Boxed Warnings: serious or fatal respiratory depression may occur. Other Notes: lowers seizure threshold. |
| Hydrocodone & Acetaminophen/ Lortab, Vicodin, Norco (PO) | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related). US Boxed Warnings (all opioid analgesics): See above. |
| Oxycodone & Acetaminophen/ Percocet, Endocet, Roxicet (PO) | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related). US Boxed Warnings (all opioid analgesics): See above |
| Codeine & Acetaminophen/ Tylenol with codeine #3, #4 (PO) | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related). US Boxed Warnings (all opioid analgesics): See above. |
| Naloxone/ Narcan (IV, IM, SQ, intranasal) | Key Side Effects: headache, opioid withdrawal syndrome in opioid-dependent populations, pain, diaphoresis. Other Notes: potentially life-threatening respiratory depression (when combined with other CNS and respiratory depressants); addition of naloxone to buprenorphine reduces possibility of parenteral misuse by producing opioid withdrawal symptoms when injected. |
| Buprenorphine & Naloxone/ Suboxone (SL) | Key Side Effects: headache, opioid withdrawal syndrome in opioid-dependent populations, pain, diaphoresis. Other Notes: potentially life-threatening respiratory depression (when combined with other CNS and respiratory depressants); addition of naloxone to buprenorphine reduces possibility of parenteral misuse by producing opioid withdrawal symptoms when injected. |